The proposed surgical research addresses critical mechanisms in maintenance of an intact intestinal mucosal barrier, and in S1P, a potential therapy to preserve this function in critically ill patients. Critical illness, particularly in surgical patients, is very common, and a high percentage of patients in the intensive care units incur stress-related injuries to their very vulnerable GI mucosa, leading to barrier dysfunction. This leads to malnutrition, translocation of bacteria, immune dysregulation, and fluid and electrolyte disorders. Despite the medical advances of the past few decades, therapies for these gastrointestinal injuries are, for the most part, conservative, as there is no current pharmacologic therapy available. The bioactive sphingolipid sphingosine-1-phosphate (S1P) has recently demonstrated significant effects on endothelial cells in promoting important biological functions, such as survival of injured cells, reparative proliferation of cells, and especially preservation of barrier function. S1P's effects are mediated through specific cell surface receptors (S1PR) which govern intracellular cytoskeletal organization and in particular regulate the organization and function of the adherens and tight junction proteins. We have demonstrated in both previously published work and in our preliminary data that S1P modulates biological functions critical to maintenance of GI barrier function by mechanisms that have not previously been studied, and which may differ significantly from those that govern endothelial barrier function. We therefore propose to investigate whether S1P promotes intestinal epithelial cell barrier integrity through increased adherens and tight junction protein expression and function, mediated primarily by extracellular S1P interaction with G-protein coupled receptors. To study this we will 1) Define the role of S1P in regulating the expression of intestinal barrier proteins using in vitro cell culture, 2) Determine the mechanism by which S1P promotes intestinal barrier function using in vitro cell culture, and 3) Determine whether S1P can maintain barrier integrity in in vivo models (human and mouse) of barrier dysfunction. We postulate that S1P modulates biological functions critical to maintenance of GI barrier function by mechanisms that have not previously been studied, and which may differ significantly from those that govern endothelial barrier function. Further, if the intracellular and intercellular mechanisms that mediate these effects are better delineated, this pathway can be targeted so as to attenuate, prevent, or even reverse GI mucosal barrier dysfunction in critically ill veterans.

Public Health Relevance

Abnormalities in gastrointestinal mucosal healing contribute the pathophysiology of several diseases such as postsurgical healing, trauma, stress ulceration and gastritis, and inflammatory bowel disease among many others. Unfortunately, these are exceedingly common in the Veteran population, including nearly every patient in our intensive care unit, and contribute greatly to their morbidity and mortality. Pharmacologic therapies have been seen to benefit care tremendously, as in the targeting of stomach acid production by proton pump inhibitors, greatly reducing the need for additional surgeries and improved outcomes in these same patients. If we can similarly target the pathway inhibiting mucosal healing, then this would potentially facilitate recovery in septic Veteran patients.

National Institute of Health (NIH)
Veterans Affairs (VA)
Non-HHS Research Projects (I01)
Project #
Application #
Study Section
Surgery (SURG)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Baltimore VA Medical Center
United States
Zip Code
Hansraj, Natasha Z; Xiao, Lan; Wu, Jing et al. (2016) Posttranscriptional regulation of 14-3-3? by RNA-binding protein HuR modulating intestinal epithelial restitution after wounding. Physiol Rep 4:
Phatak, P; Byrnes, K A; Mansour, D et al. (2016) Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1. Oncogene 35:2087-97
Byrnes, Kimberly A; Phatak, Pornima; Mansour, Daniel et al. (2016) Overexpression of miR-199a-5p decreases esophageal cancer cell proliferation through repression of mitogen-activated protein kinase kinase kinase-11 (MAP3K11). Oncotarget 7:8756-70
Chung, Hee Kyoung; Chen, Yu; Rao, Jaladanki N et al. (2015) Transgenic Expression of miR-222 Disrupts Intestinal Epithelial Regeneration by Targeting Multiple Genes Including Frizzled-7. Mol Med 21:676-687
Ouyang, Miao; Su, Weijie; Xiao, Lan et al. (2015) Modulation by miR-29b of intestinal epithelium homoeostasis through the repression of menin translation. Biochem J 465:315-23
Rathor, Navneeta; Chung, Hee K; Wang, Shelley R et al. (2014) Caveolin-1 enhances rapid mucosal restitution by activating TRPC1-mediated Ca2+ signaling. Physiol Rep 2:
Chung, Hee Kyoung; Rao, Jaladanki N; Zou, Tongtong et al. (2014) Jnk2 deletion disrupts intestinal mucosal homeostasis and maturation by differentially modulating RNA-binding proteins HuR and CUGBP1. Am J Physiol Cell Physiol 306:C1167-75
Cao, Shan; Xiao, Lan; Rao, Jaladanki N et al. (2014) Inhibition of Smurf2 translation by miR-322/503 modulates TGF-?/Smad2 signaling and intestinal epithelial homeostasis. Mol Biol Cell 25:1234-43
Rathor, Navneeta; Zhuang, Ran; Wang, Jian-Ying et al. (2014) Src-mediated caveolin-1 phosphorylation regulates intestinal epithelial restitution by altering Ca(2+) influx after wounding. Am J Physiol Gastrointest Liver Physiol 306:G650-8